Search results
Added:
6 years ago
In this video, Dr Gregg Stone discusses 'what is the biggest weakness of ORBITA?'.
View more
Added:
6 years ago
In this video, Dr Horst Sievert discusses the trial evidence to support the use of PFO closure devices.
View more
Added:
6 years ago
In this short video, Dr Keith G Oldroyd discusses which trials best support the use of multivessel disease percutaneous coronary intervention (MVD PCI).
View more
Added:
6 years ago
In this video, Dr Nicolas Van Mieghem discusses the question; 'are we ready to be doing TAVR in low risk patients?'.
View more
Added:
6 years ago
In this video, Dr Nicolas Van Mieghem discusses which patients he is performing TAVR in now.
View more
Added:
2 years ago
Prof Nicolas van Mieghem & Dr Joost Daemen (Erasmus MC, Rotterdam, NL) preview and discuss the late-breaking trials of EuroPCR 2021.
View more
Added:
11 months ago
EuroPCR 23 — We are joined by Dr Mirvat Alasnag (The King Fahd Armed Forces Hospital, SA) for an insightful summary of three late-breaking trials that are expected to have a impact on interventional science and clinical practice.
Trials covered in detail include:
EBC TWO Five Year Follow-Up: Two-Stent Vs One for Large Bifurcation Lesions
BASILICA Vs Chimney-Stenting for TAVR-Related Coronary…
View more
Added:
5 years ago
Dr Alaide Chieffo (San Raffaele Hospital, Milan, IT) discusses The BIONICS study - A review of the 2 year outcomes of theBIONICS trial on the EluNIR DES.
Filmed on-site at EuroPCR 2018 in Paris, FR.
View more
Navjyot Kaur
Author
Added:
5 years ago
Dr Steven Yakubov (OhioHealth Riverside Methodist Hospital, Columbus, OH, US) discusses 1-year outcomes of TAVR vs SAVR in patients at intermediate surgical risk - a propensity-match analysis from the SURTAVI trial.
Filmed on site at CRT 2019 by Radcliffe Cardiology
Questions:
1. Why did you conduct this analysis?
2. How was data collected and analysed?
3. What were your findings?
4. How…
View more
« First